California digital pharmacy Alto Pharmacy raised $50m for the expansion of its geographical spread and its list of products to include those for chronic and complex therapies. The company has also been working on a new product called Aperio that is designed specifically for patients with multiple sclerosis (MS). The company currently offers dermatology, fertility, biologics and HIV treatments and said it could now expand to include diabetes, heart disease and rheumatoid arthritis. It runs a same-day delivery service for prescriptions and offers management software aimed at cutting the administration workload for insurers and medical professionals.
California digital pharmacy Alto Pharmacy raised $50m for the expansion of its geographical spread and its list of products to include those for chronic and complex therapies. The series C funding was led by Zola Global and Greenoaks Capital with backing from Jackson Square Ventures, Olive Tree Capital and others. The company currently offers dermatology, fertility, biologics and HIV treatments and said it could now expand to include diabetes, heart disease and rheumatoid arthritis. It runs a same-day delivery service for prescriptions and offers management software aimed at cutting the administration workload for insurers and medical professionals.